focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCambridge Cog Share News (COG)

Share Price Information for Cambridge Cog (COG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 45.00
Bid: 44.00
Ask: 46.00
Change: 0.00 (0.00%)
Spread: 2.00 (4.545%)
Open: 45.00
High: 45.00
Low: 45.00
Prev. Close: 45.00
COG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Cambridge Cognition swings to interim loss amid ballooning costs

Tue, 26th Sep 2023 12:00

(Alliance News) - Cambridge Cognition Holdings PLC on Tuesday reported an interim loss as costs increased significantly.

Cambridge Cognition is a Cambridgeshire, England-based company which develops and markets digital solutions to assess brain health.

The company said its pretax loss in the first half of 2023 totalled GBP3.4 million, swinging from a profit of GBP16,000 a year ago. Revenue rose 2.7% to GBP6.0 million from GBP5.9 million. Administrative expenses, however, ballooned by 89% to GBP8.4 million from GBP4.5 million.

"Trading conditions continued to be difficult in the first half of 2023, with some drug development companies cutting costs and others delaying clinical trials. Some companies providing solutions and services for clinical trials have reported declining performance in the period. While we increased the value of contracted orders from half-to-half, we did see some delays to contract awards that we anticipate will close in the second half of 2023 or in 2024," the firm said.

Cambridge Cognition said that the market had improved, with its contract order book rising to GBP19.9 million at the end of June from GBP17.6 million at the end of December.

Looking ahead, it expects 2023 revenue in line with analysts' consensus, of around GBP14 million. That would be 11% higher than GBP12.6 million in 2022, as the company is eyeing "a major step towards profitability in the second half of 2023".

Separately, the company announced that it received a GBP3 million term loan from Claret European Specialty Lending Company III Sarl, which specialises in providing growth capital to innovative businesses.

The loan has an annual 11.5% fixed interest rate and will be drawn down in full immediately, with a term of 36 months.

The company will use the loan to focus on executing its strategy of growth.

Cambridge Cognition shares fell 18% to 78.10 pence each on Tuesday morning in London.

By Tom Budszus, Alliance News reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
8 Apr 2021 11:24

AIM WINNERS & LOSERS: Minds + Machines up on USD120 million asset sale

AIM WINNERS & LOSERS: Minds + Machines up on USD120 million asset sale

Read more
30 Mar 2021 16:03

IN BRIEF: Cambridge Cognition wins contract for schizophrenia trial

IN BRIEF: Cambridge Cognition wins contract for schizophrenia trial

Read more
30 Mar 2021 13:56

Cambridge Cognition wins fourth schizophrenia trial contract

(Sharecast News) - Cambridge Cognition has won a £1.3m contract as the cognitive assessment partner for a schizophrenia trial, it announced on Tuesday.

Read more
23 Mar 2021 11:58

Cambridge Cognition shares surge as it eyes profitability in 2021

Cambridge Cognition shares surge as it eyes profitability in 2021

Read more
16 Mar 2021 15:53

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
19 Jan 2021 13:45

Cambridge Cognition Sees "Significant" Revenue Growth During 2020

Cambridge Cognition Sees "Significant" Revenue Growth During 2020

Read more
21 Dec 2020 14:20

IN BRIEF: Cambridge Cognition Wins GBP700,000 Digital Health Contract

IN BRIEF: Cambridge Cognition Wins GBP700,000 Digital Health Contract

Read more
7 Oct 2020 18:20

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

UK TRADING UPDATE SUMMARY: Gym Group Fighting Fit With Fresh York Unit

Read more
22 Sep 2020 14:12

UK EARNINGS SUMMARY: IGas Swings Sharply To Loss As Revenue Halves

UK EARNINGS SUMMARY: IGas Swings Sharply To Loss As Revenue Halves

Read more
15 Sep 2020 15:53

UK Earnings, Trading Statements Calendar - Next 7 Days

UK Earnings, Trading Statements Calendar - Next 7 Days

Read more
14 Sep 2020 13:13

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

IN BRIEF: Cambridge Cognition Hires Diurnal CFO Bungay As Non-Exec

Read more
1 Sep 2020 16:22

Cambridge Cognition wins £2m contract with pharma firm

(Sharecast News) - Brain health company Cambridge Cognition has won a £2m contract as the cognitive assessment partner for three late-phase clinical trials for a pharmaceutical company's lead drug candidate for patients with schizophrenia, it announced on Tuesday.

Read more
1 Sep 2020 11:57

Cambridge Cognition Secures GBP2 Million Deal For Schizophrenia Trials

Cambridge Cognition Secures GBP2 Million Deal For Schizophrenia Trials

Read more
27 Jul 2020 17:58

UK EXECUTIVE CHANGE SUMMARY: Provident Financial Taps Former MP James

UK EXECUTIVE CHANGE SUMMARY: Provident Financial Taps Former MP James

Read more
20 Jul 2020 15:53

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.